Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Wai Yuen Tong Medicine Holdings stock price, quote, forecast and news

897.HK
BMG9421Y2332

Price

0.19
Today +/-
-0.00
Today %
-4.08 %
P

Wai Yuen Tong Medicine Holdings stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Wai Yuen Tong Medicine Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Wai Yuen Tong Medicine Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Wai Yuen Tong Medicine Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Wai Yuen Tong Medicine Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Wai Yuen Tong Medicine Holdings Stock Price History

DateWai Yuen Tong Medicine Holdings Price
9/4/20240.19 undefined
9/3/20240.20 undefined
9/2/20240.20 undefined
8/30/20240.20 undefined
8/29/20240.20 undefined
8/28/20240.20 undefined
8/27/20240.20 undefined
8/26/20240.20 undefined
8/23/20240.20 undefined
8/22/20240.21 undefined
8/21/20240.39 undefined
8/20/20240.39 undefined
8/19/20240.40 undefined
8/16/20240.38 undefined
8/15/20240.37 undefined
8/14/20240.37 undefined
8/13/20240.40 undefined
8/12/20240.42 undefined
8/9/20240.41 undefined
8/8/20240.41 undefined

Wai Yuen Tong Medicine Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Wai Yuen Tong Medicine Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Wai Yuen Tong Medicine Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Wai Yuen Tong Medicine Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Wai Yuen Tong Medicine Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Wai Yuen Tong Medicine Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Wai Yuen Tong Medicine Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Wai Yuen Tong Medicine Holdings’s growth potential.

Wai Yuen Tong Medicine Holdings Revenue, EBIT and net profit per share

DateWai Yuen Tong Medicine Holdings RevenueWai Yuen Tong Medicine Holdings EBITWai Yuen Tong Medicine Holdings Net Income
2024783.88 M undefined48.84 M undefined-15.36 M undefined
2023723.6 M undefined11.25 M undefined-20.52 M undefined
20221.39 B undefined118.58 M undefined-108.91 M undefined
20211.11 B undefined40.72 M undefined-376 M undefined
2020620.74 M undefined-114.63 M undefined438.55 M undefined
2019751.44 M undefined-129.82 M undefined74.63 M undefined
2018845.78 M undefined-97.7 M undefined-115.58 M undefined
2017738.44 M undefined-23.44 M undefined-93.3 M undefined
2016825.33 M undefined15.97 M undefined25.39 M undefined
2015831.09 M undefined-53.33 M undefined120.98 M undefined
2014865.3 M undefined28.3 M undefined163.4 M undefined
2013808.5 M undefined25.8 M undefined148.4 M undefined
2012752.1 M undefined49.8 M undefined-226.9 M undefined
2011639.5 M undefined25.2 M undefined99.1 M undefined
2010529.3 M undefined16.8 M undefined45.8 M undefined
2009496.2 M undefined-17 M undefined-345.9 M undefined
2008477 M undefined1.1 M undefined83.8 M undefined
2007381.3 M undefined-3 M undefined9.9 M undefined
2006324.8 M undefined-40.6 M undefined-98.4 M undefined
2005326.9 M undefined-19 M undefined-67 M undefined

Wai Yuen Tong Medicine Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (B)DOCUMENTS
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
0.240.220.260.350.330.320.380.480.50.530.640.750.810.870.830.830.740.850.750.621.111.390.720.78
--8.3317.7334.75-6.59-0.6117.5925.203.986.6520.7917.687.457.05-3.93-0.72-10.5514.50-11.12-17.4478.7125.54-48.028.30
26.2532.7343.2444.4150.3141.0545.9346.3345.9747.6447.1047.0745.1744.9742.2444.8542.0140.5940.0845.3239.5340.9847.3050.32
6372112155164133175221228252301354365389351370310343301281438570342394
-23-24-18-27-19-40-31-171625492528-5315-23-97-129-114401181148
-9.58-10.91-6.95-7.74-5.83-12.35-0.790.21-3.433.023.916.523.093.24-6.381.82-3.12-11.48-17.18-18.393.618.481.526.13
-31-33-28-30-67-98983-3454599-22614816312025-93-11574438-375-108-20-15
-6.45-15.157.14123.3346.27-109.18822.22-515.66-113.04120.00-328.28-165.4910.14-26.38-79.17-472.0023.66-164.35491.89-185.62-71.20-81.48-25.00
000000.010.010.010.010.030.080.120.130.170.230.340.881.271.251.231.231.231.221.18
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Wai Yuen Tong Medicine Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Wai Yuen Tong Medicine Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                               
4.66.821.532.643.5123.3262.5120.661103.7275197.5413.3396444.17402.68474548.44903.29591.02666.63645.18579.34196.78
30.622.231.748.390.759.169.380.343.345.165.386.795.4135.7115.12234.62172.91189.5692.2166.4753.0663.0667.2881.36
0021220.115105.637.525.854.5141.6246.6119.632.4714.7646.55142.825.19172.45189.2113.09128.04135.57
0.040.030.050.030.070.070.070.10.080.070.10.110.150.150.150.150.170.180.162.12.121.871.640.31
0000046.32.54.42.841.30044.263.4122.7921.7700167.12168.61207.15198.41291.12108.43
0.070.060.10.130.220.310.410.310.230.290.490.540.950.860.870.830.861.061.353.13.232.892.70.83
34.222.53018.2253.184.937.256.358.427.2146172.6210.9247.3516.74771.61834.11809.38957.32974.94961.78956.4961.16665.46
000.010.030.050.040.020.380.320.610.860.680.640.771.421.611.771.711.123.643.753.723.30.19
000.8007.32000204.3285.6221.3186.44500080000013.3417.21380
000.50.80.7141.998.6100.997.390.80.70.70.50.40.410.290.210000000
00179.6293.8296.5255.5206.125.315.315.315.315.315.315.315.3415.3415.347.7000000
000000.30.3335.8363.373.751.95.26.9310.8413.7662.6731.8219.9519.1816.6128.732.11
0.040.030.220.340.60.530.380.90.530.951.311.091.11.491.962.412.712.592.114.634.734.714.311.26
0.110.080.320.470.830.840.791.20.751.241.81.632.052.352.823.243.573.663.457.737.967.67.012.1
                                               
13.213.2157.955.334.9141416.820.160.720.420.429.329.342.173.1612.6512.6512.3212.3212.3212.3212.0511.71
000000.550.5500.721.131.21.21.341.341.52002.122.112.112.112.112.11.13
-0.03-0.06-0.070.30.560.080.090.87-0.16-0.10.320.090.250.40.512.322.640.390.330.620.290.160.110.22
000001.22.106.99.722.837.330.932.823.2004.7-34.39-121.6856.46136.8522.94-6.38
000000000023.423.42828-65.390029.4528.0128.01104.12104.12104.1228.01
-0.01-0.050.090.350.590.650.660.890.591.11.581.361.681.832.042.322.652.552.442.642.572.522.351.39
67.648.45629.564.453.573.269.925.82838.645.664.964.981.5200035.9666.7172.286.3679.4930.91
000000000013.720.914.617.432.54000082.1686.8189.2682.995.21
00.010.0300000.010.040.060.030.030.020.030.110.160.150.160.110.931.340.940.760.06
8.2000000025000000000000000
20.5614.61330.738.615.41316.21233.369222.7201.8199.22158.9362.29264.79232.29794.56869.28763.31732.16283.87
0.10.060.10.040.10.090.090.090.110.10.110.160.330.320.430.320.210.430.381.872.371.881.660.38
0.030.070.130.070.130.090.040.220.050.040.090.070.040.190.350.580.70.660.620.970.91.041.030.28
000.20.43.422.11.10.10.216.522.71.62.61.537.325.876.383.42633.92685.44642.3569.381.36
000.50.40.10000000000002.451.88262.8156.972.5966.451.22
0.030.070.130.070.130.10.050.220.050.040.10.090.040.190.350.590.70.670.631.861.641.761.670.33
0.120.130.230.120.230.190.140.310.150.130.210.260.370.510.780.910.921.11.013.744.013.643.330.71
0.110.080.320.470.820.840.791.20.751.231.791.622.042.342.823.233.573.653.456.386.586.155.672.1
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Wai Yuen Tong Medicine Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Wai Yuen Tong Medicine Holdings's financial health and stability.

Assets

Wai Yuen Tong Medicine Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Wai Yuen Tong Medicine Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Wai Yuen Tong Medicine Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Wai Yuen Tong Medicine Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-31-33-18-27-41-1071085-34547125-21314817112029-96-11481455-303-47-11
911152110191918201711131619151414465111292107113
00000000000000000000000
15-7-6-25-5224107-3943-163-10-47-3584-680-3243-55225-142-78
414302769-14-87337-28-80244-127-140-162-91-723-202-545397234143
55472763321227101416182845845886
0021320130118120012-2013898153
-1-14-5-32-565123-221640-10633-91557-115-89-76-26-32412152165
-6-3-6-10-39-8-8-11-17-5-6-40-34-55-285-282-78-63-16-6-59-26-33
-5-3-5-12-219-5884-367-4-7-224-56-47-191-434-325-19223-102425-642221
101-2-179-4992-35612-2-218-16-12-135-149-43-11386-85432-44855
00000000000000000000000
-122423-942-27-73132-105-39432112212815818820167-74-36-266-89-51
150515429015301245335364015802022274080-9000-9
0252551290118-79253-54-839713273111335396404149-113-81-350-204-158
-1.00--4.00-7.00-2.00-7.00-6.00-3.00-2.00-3.00-10.00-2.00-7.00-7.00-16.00-20.00-23.00-17.00-28.00-45.00-84.00-114.00-96.00
00000000000-60-8-800000000
-661461564128-136-422467-9216-63-41-4511897-24930431216
-8.1-18.4-11.5-43.1-96.1-3.5115.5-34.6-0.234.6-113.4-6.8-44.6-40.3-227.69-397.78-168.28-140.31-43.6-39.33353.05126.24132.37
00000000000000000000000

Wai Yuen Tong Medicine Holdings stock margins

The Wai Yuen Tong Medicine Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Wai Yuen Tong Medicine Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Wai Yuen Tong Medicine Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Wai Yuen Tong Medicine Holdings's sales revenue. A higher gross margin percentage indicates that the Wai Yuen Tong Medicine Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Wai Yuen Tong Medicine Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Wai Yuen Tong Medicine Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Wai Yuen Tong Medicine Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Wai Yuen Tong Medicine Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Wai Yuen Tong Medicine Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Wai Yuen Tong Medicine Holdings Margin History

Wai Yuen Tong Medicine Holdings Gross marginWai Yuen Tong Medicine Holdings Profit marginWai Yuen Tong Medicine Holdings EBIT marginWai Yuen Tong Medicine Holdings Profit margin
202450.37 %6.23 %-1.96 %
202347.31 %1.55 %-2.84 %
202240.99 %8.52 %-7.83 %
202139.6 %3.67 %-33.92 %
202045.36 %-18.47 %70.65 %
201940.13 %-17.28 %9.93 %
201840.65 %-11.55 %-13.67 %
201742.08 %-3.17 %-12.64 %
201644.86 %1.93 %3.08 %
201542.24 %-6.42 %14.56 %
201445.01 %3.27 %18.88 %
201345.18 %3.19 %18.35 %
201247.12 %6.62 %-30.17 %
201147.16 %3.94 %15.5 %
201047.69 %3.17 %8.65 %
200946.09 %-3.43 %-69.71 %
200846.42 %0.23 %17.57 %
200745.97 %-0.79 %2.6 %
200641.23 %-12.5 %-30.3 %
200550.41 %-5.81 %-20.5 %

Wai Yuen Tong Medicine Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Wai Yuen Tong Medicine Holdings earnings per share therefore indicates how much revenue Wai Yuen Tong Medicine Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Wai Yuen Tong Medicine Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Wai Yuen Tong Medicine Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Wai Yuen Tong Medicine Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Wai Yuen Tong Medicine Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Wai Yuen Tong Medicine Holdings Revenue, EBIT and net profit per share

DateWai Yuen Tong Medicine Holdings Sales per ShareWai Yuen Tong Medicine Holdings EBIT per shareWai Yuen Tong Medicine Holdings Earnings per Share
20240.66 undefined0.04 undefined-0.01 undefined
20230.59 undefined0.01 undefined-0.02 undefined
20221.13 undefined0.1 undefined-0.09 undefined
20210.9 undefined0.03 undefined-0.31 undefined
20200.5 undefined-0.09 undefined0.36 undefined
20190.6 undefined-0.1 undefined0.06 undefined
20180.67 undefined-0.08 undefined-0.09 undefined
20170.84 undefined-0.03 undefined-0.11 undefined
20162.42 undefined0.05 undefined0.07 undefined
20153.64 undefined-0.23 undefined0.53 undefined
20145.07 undefined0.17 undefined0.96 undefined
20136.44 undefined0.21 undefined1.18 undefined
20126.34 undefined0.42 undefined-1.91 undefined
20118.47 undefined0.33 undefined1.31 undefined
201016.19 undefined0.51 undefined1.4 undefined
200941.35 undefined-1.42 undefined-28.82 undefined
200848.67 undefined0.11 undefined8.55 undefined
200744.86 undefined-0.35 undefined1.16 undefined
200664.96 undefined-8.12 undefined-19.68 undefined
2005233.5 undefined-13.57 undefined-47.86 undefined

Wai Yuen Tong Medicine Holdings business model

Wai Yuen Tong Medicine Holdings is one of the most popular companies on Eulerpool.com.

Wai Yuen Tong Medicine Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Wai Yuen Tong Medicine Holdings historical P/E ratio, EBIT, and P/S ratio.

Wai Yuen Tong Medicine Holdings shares outstanding

The number of shares was Wai Yuen Tong Medicine Holdings in 2023 — This indicates how many shares 1.216 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Wai Yuen Tong Medicine Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Wai Yuen Tong Medicine Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Wai Yuen Tong Medicine Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Wai Yuen Tong Medicine Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Wai Yuen Tong Medicine Holdings Stock splits

In Wai Yuen Tong Medicine Holdings's history, there have been no stock splits.

Wai Yuen Tong Medicine Holdings dividend history and estimates

In 2023, Wai Yuen Tong Medicine Holdings paid a dividend amounting to 0 HKD. Dividend means that Wai Yuen Tong Medicine Holdings distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Wai Yuen Tong Medicine Holdings provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Wai Yuen Tong Medicine Holdings’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Wai Yuen Tong Medicine Holdings's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Wai Yuen Tong Medicine Holdings Dividend History

DateWai Yuen Tong Medicine Holdings Dividend
20240.15 undefined
20140.06 undefined
20130.06 undefined
20110.06 undefined

Wai Yuen Tong Medicine Holdings dividend payout ratio

In 2023, Wai Yuen Tong Medicine Holdings had a payout ratio of 5.74%. The payout ratio indicates the percentage of the company's profits that Wai Yuen Tong Medicine Holdings distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Wai Yuen Tong Medicine Holdings represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Wai Yuen Tong Medicine Holdings could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Wai Yuen Tong Medicine Holdings's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Wai Yuen Tong Medicine Holdings Payout Ratio History

DateWai Yuen Tong Medicine Holdings Payout ratio
20245.74 %
20235.74 %
20225.74 %
20215.73 %
20205.76 %
20195.73 %
20185.69 %
20175.85 %
20165.66 %
20155.58 %
20146.32 %
20135.08 %
20125.33 %
20114.58 %
20105.33 %
20095.33 %
20085.33 %
20075.33 %
20065.33 %
20055.33 %
Unfortunately, there are currently no price targets and forecasts available for Wai Yuen Tong Medicine Holdings.

Wai Yuen Tong Medicine Holdings list of shareholders

%
Name
Stocks
Change
Date
72.02 % Wang On Group Ltd810,322,94008/10/2023
1

Wai Yuen Tong Medicine Holdings Executives and Management Board

Mr. Ching Ho Tang60
Wai Yuen Tong Medicine Holdings Executive Chairman of the Board, Managing Director (since 2001)
Compensation 8.71 M
Ms. Wai Man Tang31
Wai Yuen Tong Medicine Holdings Executive Director (since 2018)
Compensation 1.29 M
Ms. Man Yee Law59
Wai Yuen Tong Medicine Holdings Executive Director (since 2021)
Compensation 788,000
Mr. Ka Fai Li68
Wai Yuen Tong Medicine Holdings Independent Non-Executive Director
Compensation 204,000
Mr. Man Ho Siu49
Wai Yuen Tong Medicine Holdings Independent Non-Executive Director
Compensation 184,000
1
2
3

Wai Yuen Tong Medicine Holdings Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Wang On Group Stock
Wang On Group
SupplierCustomer0,690,510,190,250,18-0,25
Hong Kong Technology Venture Stock
Hong Kong Technology Venture
SupplierCustomer0,65-0,420,030,600,630,63
Alibaba Group Holding Stock
Alibaba Group Holding
SupplierCustomer0,510,150,110,670,520,26
JD com A Stock
JD com A
SupplierCustomer0,11-0,420,090,660,64-
China Agri-Products Stock
China Agri-Products
SupplierCustomer0,040,08-0,100,520,400,39
1

Most common questions regarding Wai Yuen Tong Medicine Holdings

What is the P/E ratio of Wai Yuen Tong Medicine Holdings 2024?

The Wai Yuen Tong Medicine Holdings P/E ratio is -14.77.

What is the P/S ratio of Wai Yuen Tong Medicine Holdings 2024?

The Wai Yuen Tong Medicine Holdings P/S ratio is 0.29.

What is the AlleAktien quality score of Wai Yuen Tong Medicine Holdings?

The AlleAktien quality score for Wai Yuen Tong Medicine Holdings is 2/10.

What is the revenue of Wai Yuen Tong Medicine Holdings 2024?

The Wai Yuen Tong Medicine Holdings revenue is 783.88 M HKD.

How high is the profit of Wai Yuen Tong Medicine Holdings 2024?

The Wai Yuen Tong Medicine Holdings profit is -15.36 M HKD.

What is the business model of Wai Yuen Tong Medicine Holdings

No history available for Wai Yuen Tong Medicine Holdings.

What is the Wai Yuen Tong Medicine Holdings dividend?

Wai Yuen Tong Medicine Holdings pays a dividend of 0 HKD distributed over payouts per year.

How often does Wai Yuen Tong Medicine Holdings pay dividends?

The dividend cannot currently be calculated for Wai Yuen Tong Medicine Holdings or the company does not pay out a dividend.

What is the Wai Yuen Tong Medicine Holdings ISIN?

The ISIN of Wai Yuen Tong Medicine Holdings is BMG9421Y2332.

What is the Wai Yuen Tong Medicine Holdings ticker?

The ticker of Wai Yuen Tong Medicine Holdings is 897.HK.

How much dividend does Wai Yuen Tong Medicine Holdings pay?

Over the past 12 months, Wai Yuen Tong Medicine Holdings paid a dividend of 0.15 HKD . This corresponds to a dividend yield of about 76.56 %. For the coming 12 months, Wai Yuen Tong Medicine Holdings is expected to pay a dividend of 0.15 HKD.

What is the dividend yield of Wai Yuen Tong Medicine Holdings?

The current dividend yield of Wai Yuen Tong Medicine Holdings is 76.56 %.

When does Wai Yuen Tong Medicine Holdings pay dividends?

Wai Yuen Tong Medicine Holdings pays a quarterly dividend. This is distributed in the months of September, September, August, September.

How secure is the dividend of Wai Yuen Tong Medicine Holdings?

Wai Yuen Tong Medicine Holdings paid dividends every year for the past 1 years.

What is the dividend of Wai Yuen Tong Medicine Holdings?

For the upcoming 12 months, dividends amounting to 0.15 HKD are expected. This corresponds to a dividend yield of 76.56 %.

In which sector is Wai Yuen Tong Medicine Holdings located?

Wai Yuen Tong Medicine Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Wai Yuen Tong Medicine Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Wai Yuen Tong Medicine Holdings from 9/6/2024 amounting to 0.147 HKD, you needed to have the stock in your portfolio before the ex-date on 8/22/2024.

When did Wai Yuen Tong Medicine Holdings pay the last dividend?

The last dividend was paid out on 9/6/2024.

What was the dividend of Wai Yuen Tong Medicine Holdings in the year 2023?

In the year 2023, Wai Yuen Tong Medicine Holdings distributed 0 HKD as dividends.

In which currency does Wai Yuen Tong Medicine Holdings pay out the dividend?

The dividends of Wai Yuen Tong Medicine Holdings are distributed in HKD.

All fundamentals about Wai Yuen Tong Medicine Holdings

Our stock analysis for Wai Yuen Tong Medicine Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wai Yuen Tong Medicine Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.